Cargando…

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

Baseline clinical prognostic factors for recurrent and/or metastatic (RM) head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy are lacking. CT-based radiomics may provide additional prognostic information. A total of 85 patients with RM-HNSCC were enrolled for this study. For eac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corino, Valentina D. A., Bologna, Marco, Calareso, Giuseppina, Licitra, Lisa, Ghi, Mariagrazia, Rinaldi, Gaetana, Caponigro, Francesco, Morelli, Franco, Airoldi, Mario, Allegrini, Giacomo, Cassano, Alessandra, Ferrari, Daris, Mirabile, Aurora, Tosoni, Alicia, Galizia, Danilo, Merlano, Marco, Sponghini, Andrea, Moretti, Gabriella, Mainardi, Luca, Bossi, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229740/ https://www.ncbi.nlm.nih.gov/pubmed/34071518 http://dx.doi.org/10.3390/diagnostics11060979

Ejemplares similares

Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy
por: Corino, Valentina D. A., et al.
Publicado: (2022)

Assessment of Stability and Discrimination Capacity of Radiomic Features on Apparent Diffusion Coefficient Images
por: Bologna, Marco, et al.
Publicado: (2018)

Technical Note: Virtual phantom analyses for preprocessing evaluation and detection of a robust feature set for MRI‐radiomics of the brain
por: Bologna, Marco, et al.
Publicado: (2019)

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment
por: Merlano, Marco Carlo, et al.
Publicado: (2023)

Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients
por: Bologna, Marco, et al.
Publicado: (2020)

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
por: Cavalieri, Stefano, et al.
Publicado: (2022)

MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures
por: Corti, Anna, et al.
Publicado: (2023)

Diffusion-weighted MRI radiomics of spine bone tumors: feature stability and machine learning-based classification performance
por: Gitto, Salvatore, et al.
Publicado: (2022)

How I treat squamous ENT cancer
por: Merlano, Marco Carlo, et al.
Publicado: (2019)

The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial
por: Botticelli, Andrea, et al.
Publicado: (2020)

How Risk Factors Affect Head and Neck Squamous Cell Carcinoma (HNSCC) Tumor Immune Microenvironment (TIME): Their Influence on Immune Escape Mechanisms and Immunotherapy Strategy
por: Galizia, Danilo, et al.
Publicado: (2022)

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
por: Merlano, Marco C., et al.
Publicado: (2018)

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
por: Bossi, Paolo, et al.
Publicado: (2017)

A Detector for Premature Atrial and Ventricular Complexes
por: García-Isla, Guadalupe, et al.
Publicado: (2021)

3D vs. 2D MRI radiomics in skeletal Ewing sarcoma: Feature reproducibility and preliminary machine learning analysis on neoadjuvant chemotherapy response prediction
por: Gitto, Salvatore, et al.
Publicado: (2022)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
por: Ferrari, Daris, et al.
Publicado: (2020)

Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?
por: Bossi, Paolo, et al.
Publicado: (2021)

Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer: A Phase II Trial
por: Locati, Laura D., et al.
Publicado: (2021)

ASCO highlights podcast: head and neck cancers
por: Merlano, Marco
Publicado: (2016)

Heart Rate Variability and Clinical Features as Predictors of Atrial Fibrillation Recurrence After Catheter Ablation: A Pilot Study
por: Saiz-Vivo, Javier, et al.
Publicado: (2021)

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review
por: Merlano, Marco Carlo, et al.
Publicado: (2022)

Safety and efficacy of vemurafenib in BRAF V600E mutation-positive metastatic melanomas
por: Sponghini, Andrea P, et al.
Publicado: (2015)

Assessment of the dynamics of atrial signals and local atrial period series during atrial fibrillation: effects of isoproterenol administration
por: Mainardi, Luca T, et al.
Publicado: (2004)

Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
por: Merlano, Marco, et al.
Publicado: (2007)

Comment on ‘Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'
por: Bossi, Paolo, et al.
Publicado: (2015)

Atrial fibrillation episode patterns as predictor of clinical outcome of catheter ablation
por: Saiz-Vivó, Javier, et al.
Publicado: (2022)

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib
por: Abbona, Andrea, et al.
Publicado: (2023)

Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
por: Iacovelli, Nicola Alessandro, et al.
Publicado: (2020)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression
por: Paccagnella, Matteo, et al.
Publicado: (2022)

The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: systematic review and radiomics quality score assessment
por: Spadarella, Gaia, et al.
Publicado: (2022)

Immune-related response criteria: light and shadows
por: Merlano, Marco, et al.
Publicado: (2016)

Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer’
por: Bossi, Paolo, et al.
Publicado: (2018)

Automatic segmentation of optical coherence tomography pullbacks of coronary arteries treated with bioresorbable vascular scaffolds: Application to hemodynamics modeling
por: Bologna, Marco, et al.
Publicado: (2019)

The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients
por: Cavalieri, Stefano, et al.
Publicado: (2022)

Primary DNA damage and genetic polymorphisms for CYP1A1, EPHX and GSTM1 in workers at a graphite electrode manufacturing plant
por: Moretti, Massimo, et al.
Publicado: (2007)

Into the Clinic With Nivolumab and Pembrolizumab
por: Shu, Catherine A., et al.
Publicado: (2016)

Focus on Nivolumab in NSCLC
por: Cortinovis, Diego L., et al.
Publicado: (2016)

Nivolumab‐induced sialadenitis
por: Takahashi, Saeko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1mhn1g3ka4hcht73t2i9k0mslh